Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

European phase III study to begin for SP-01A in HIV

June 19, 2006

Maturation inhibitor bevirimat begins phase IIb study

June 15, 2006

Update on study of Aptivus in treatment-naive HIV patients

June 14, 2006

Novel treatment for HIV infection reported by Panacos

June 8, 2006

New HIV reverse transcriptase inhibitors reported in recent Tibotec patent

June 2, 2006

Reduction in viral load in 10-day HIV study of SP-01A

June 1, 2006

BioInvent considers protocol amendment for phase I/II study of BI-201 for HIV

May 31, 2006

Plans for phase II study of interferon alpha for oral warts in HIV patients

May 26, 2006

GeoVax begins studies of HIV/AIDS vaccine

May 24, 2006

Lexiva has comparable activity to the preferred HIV protease inhibitor Kaletra

May 19, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...